Wang et al. found that febuxostat as an XO-specific inhibitor showed antioxidant stress and anti-inflammatory effects and weakened the local hypoxia of renal tubular epithelial cells by inhibiting XO activity, thus alleviating SA-AKI. This evidence concerns the gene XDH and acute kidney injury.